Works matching IS 10781552 AND DT 2023 AND VI 29 AND IP 5
Results: 33
Basic concepts of cancer genetics and receptor tyrosine kinase inhibition for pharmacists. A narrative review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1187, doi. 10.1177/10781552231153814
- By:
- Publication type:
- Article
Treating multiple myeloma in the era of new drugs: What is the right choice?
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1234, doi. 10.1177/10781552231176499
- By:
- Publication type:
- Article
Clinical clerkship at an oncology hospital based on the curriculum of a clinical pharmacy program from a university belonging to low-middle-income country: Insights from a pharmacy program experience.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1227, doi. 10.1177/10781552231174784
- By:
- Publication type:
- Article
Pharmacokinetic approach in therapeutic monitoring of antineoplastic drugs and the impact on pharmacoeconomics: A systematic review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1218, doi. 10.1177/10781552231171827
- By:
- Publication type:
- Article
Updates in the use of targeted therapies for the treatment of cholangiocarcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1206, doi. 10.1177/10781552231171079
- By:
- Publication type:
- Article
The role of the pharmacist in the hospital discharge of cancer patients: an integrative review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1196, doi. 10.1177/10781552231160678
- By:
- Publication type:
- Article
Widespread vitiligo and poliosis following ipilimumab–nivolumab combination therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1278, doi. 10.1177/10781552231154460
- By:
- Publication type:
- Article
Alectinib in a patient with ALK-positive non-small lung cancer unable to swallow capsules.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1283, doi. 10.1177/10781552231155374
- By:
- Publication type:
- Article
Ribociclib-induced hepatotoxicity.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1275, doi. 10.1177/10781552231154009
- By:
- Publication type:
- Article
Vincristine-induced ptosis in a leukemia patient treated with pyridoxine and pyridostigmine.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1271, doi. 10.1177/10781552231152414
- By:
- Publication type:
- Article
Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic mucosal melanoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1259, doi. 10.1177/10781552221148973
- By:
- Publication type:
- Article
Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev ®), a bevacizumab biosimilar, under extended in-use conditions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1032, doi. 10.1177/10781552221088020
- By:
- Publication type:
- Article
Atezolizumab induced new-onset type 1 diabetes mellitus.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1268, doi. 10.1177/10781552231151656
- By:
- Publication type:
- Article
Recurrent and atypical immune checkpoint inhibitor-induced pneumonitis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1264, doi. 10.1177/10781552221150936
- By:
- Publication type:
- Article
Tamoxifen induced hands deformities.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1246, doi. 10.1177/10781552221147507
- By:
- Publication type:
- Article
Cycle-dependent eosinophilia due to adjuvant nivolumab for malignant melanoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1255, doi. 10.1177/10781552221148968
- By:
- Publication type:
- Article
Alectinib-induced hemolytic anemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1251, doi. 10.1177/10781552221147840
- By:
- Publication type:
- Article
Genetic variants found in paediatric oncology patients with severe chemotherapy-induced toxicity: A case series.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1237, doi. 10.1177/10781552221137302
- By:
- Publication type:
- Article
Comparison of different decision support software programs in perspective of potential drug–drug interactions in the oncology clinic.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1178, doi. 10.1177/10781552221104814
- By:
- Publication type:
- Article
Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1172, doi. 10.1177/10781552221103551
- By:
- Publication type:
- Article
Management of immune-related hepatitis in patients being treated with checkpoint inhibitors for metastatic melanoma, a review and case series.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1163, doi. 10.1177/10781552221103548
- By:
- Publication type:
- Article
Adherence to oral anti-cancer therapies in older patients is similar to that of younger patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1154, doi. 10.1177/10781552221103547
- By:
- Publication type:
- Article
Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1144, doi. 10.1177/10781552221102884
- By:
- Publication type:
- Article
Associations of readiness for hospital discharge with symptoms and non-routine utilization of post-discharge services among cancer patients receiving oral chemotherapy at home: A prospective study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1135, doi. 10.1177/10781552221100720
- By:
- Publication type:
- Article
Monoclonal-induced cardiotoxicity in patients with non-Hodgkin's lymphoma and breast cancer: A retrospective study in an oncology clinic.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1125, doi. 10.1177/10781552221098426
- By:
- Publication type:
- Article
Adherence to practice guidelines for the management of febrile neutropenia in patients undergoing hematopoietic stem cell transplantation: An observational study in a referral center in Iran.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1112, doi. 10.1177/10781552221092158
- By:
- Publication type:
- Article
Incidence of bleeding events in patients on concomitant tyrosine kinase inhibitors and selective serotonin reuptake inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1119, doi. 10.1177/10781552221098044
- By:
- Publication type:
- Article
Pharmacological profile and potential drug interactions in ovarian cancer hospitalized patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1103, doi. 10.1177/10781552221091298
- By:
- Publication type:
- Article
Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1094, doi. 10.1177/10781552221091282
- By:
- Publication type:
- Article
An investigation of the use of app technology to support clinical management of patients with chronic myeloid leukaemia (CML).
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1083, doi. 10.1177/10781552221090904
- By:
- Publication type:
- Article
Health professionals' practice to care cytotoxic drug handling and associated factors: The case of university of gondar specialized hospital.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1075, doi. 10.1177/10781552221090200
- By:
- Publication type:
- Article
International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1065, doi. 10.1177/10781552221090199
- By:
- Publication type:
- Article
Pharmacists' practices and views regarding management of sexual health in patients with cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1044, doi. 10.1177/10781552221089667
- By:
- Publication type:
- Article